Press Releases

Jun 18, 2015

PharmaCyte Biotech's Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company's Future in Cannabis Research

Jun 16, 2015

PharmaCyte Biotech Showcasing Technology and Treatments at 2015 BIO International Convention

Jun 15, 2015

PharmaCyte Biotech Advances Cannabinoid Research With Schedule 1 License

Jun 12, 2015

PharmaCyte Biotech’s Diabetes Treatment to Be Presented at Austrodrugs 2015

Jun 10, 2015

PharmaCyte Biotech Officers to Attend 2015 BIO International Convention

Jun 9, 2015

PharmaCyte Biotech’s Contract Research Organization Voted Australia’s Favorite CRO for 2015

Jun 3, 2015

PharmaCyte Biotech's Cancer Treatment Shows "Complete Tumor Remission" in Published Preclinical Study

Jun 1, 2015

PharmaCyte Biotech Releases Corporate Video

May 29, 2015

PharmaCyte Biotech to Conduct Additional Study on Malignant Ascites

May 26, 2015

PharmaCyte Biotech to Attend Annual Meeting of the American Society of Clinical Oncology